PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis.
Augello C, Gianelli U, Falcone R, Tabano S, Savi F, Bonaparte E, Ciboddo M, Paganini L, Parafioriti A, Ricca D, Lonati S, Cattaneo D, Fracchiolla NS, Iurlo A, Cortelezzi A, Bosari S, Miozzo M, Sirchia SM.
Augello C, et al. Among authors: iurlo a.
Leuk Res. 2015 Feb;39(2):236-41. doi: 10.1016/j.leukres.2014.11.012. Epub 2014 Dec 2.
Leuk Res. 2015.
PMID: 25498506
Clinical Trial.